Author

Alessia Marin

University of Helsinki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Harri M. ItkoneniD· 1 shared Joyeeta Chatterjee· 1 shared Shivani YalalaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Harri M. ItkonenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2

Joyeeta Chatterjee, Alessia Marin, Shivani Yalala, Harri M. Itkonen

This study identifies CDK2 as a therapeutic target in castration-resistant prostate cancer and shows that combining CDK2 inhibitors with AR inhibitors enhances efficacy without harming normal cells.

Molecular Oncology · Sep 2, 2026Peer-reviewedCancer Biology